Lorlatinib in ALK- and ROS1-positive NSCLC: the future has a start

This is a publication. If there is no link to the publication on this page, you can try the pre-formated search via the search engines listed on this page.

Authors: Francesco Facchinetti, Luc Friboulet

Journal title: Translational Lung Cancer Research

Journal number: 7/S2

Journal publisher: AME

Published year: 2018

Published pages: S103-S106

DOI identifier: 10.21037/tlcr.2018.02.04

ISSN: 2218-6751